A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection

Clinical trial NCT07411755 · RECRUITING

Trial details

NCT number: NCT07411755
Sponsor: Jiangsu Genscend Biopharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2026-03-05
Primary completion: 2026-09-01
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.